FOREFRONT: Assessments Of Drug Safety And Effectiveness Continue To Fail
People With Obesity
 â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â
Â
View Message in Browser
<[link removed]>
[link removed]"the timing of authorized generic entry is largely strategic and
that brand manufacturers generally introduce authorized generics when
the threat of generic entry is heightened after the first traditional
generic is approved for the authorized generic's brand-name drug."
Read the Article
<[link removed]"Private Sector Solutions for Health
Equity," is sponsored by CVS Health and co-hosted by Dr. Sree Chaguturu,
Chief Medical Officer (CVS Health) and Dr. Joneigh Khaldun, Chief Health
Equity Officer (CVS Health).
The season features interviews with C-Suite level executives, such as
Karen DeSalvo (Google), Rashad Burgess (Gilead Sciences), and Thomas D.
Sequist (Massachusetts General Brigham) as they discuss private sector
initiatives and responsibility to advance health equity.
The first episode goes live next Wednesday, September 6.
Listen to the Trailer
<[link removed]
